tiprankstipranks
Trending News
More News >
CytomX Therapeutics Inc (CTMX)
NASDAQ:CTMX
US Market

CytomX Therapeutics (CTMX) Income Statement

Compare
876 Followers

CytomX Therapeutics Income Statement

Last quarter (Q3 2025), CytomX Therapeutics's total revenue was $5.96M, a decrease of -82.16% from the same quarter last year. In Q3, CytomX Therapeutics's net income was $-14.23M. See CytomX Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 138.10M$ 101.21M$ 53.16M$ 37.31M$ 68.43M
Gross Profit
$ 138.10M$ 101.21M$ 53.16M$ 37.31M$ 68.43M
Operating Expenses
$ 113.11M$ 107.70M$ 154.50M$ 153.35M$ 148.97M
Depreciation and Amortization
$ 1.77M$ 2.17M$ 2.44M$ 2.71M$ 2.57M
EBITDA
$ 26.76M$ -4.31M$ -98.89M$ -113.34M$ -77.97M
Operating Income
$ 25.00M$ -6.48M$ -101.33M$ -116.04M$ -80.54M
Other Income/Expenses
$ 7.10M$ 9.81M$ 2.02M$ 172.00K$ 29.63M
Pretax Income
$ 32.09M$ 3.32M$ -99.32M$ -115.87M$ -50.91M
Net Income
$ 31.87M$ -569.00K$ -99.32M$ -115.87M$ -64.82M
Per Share Metrics
Basic EPS
$ 0.38$ -0.01$ -1.48$ -1.26$ -0.71
Diluted EPS
$ 0.38$ -0.01$ -1.48$ -1.26$ -0.71
Weighted Average Shares Outstanding
84.44M 73.81M 65.74M 64.15M 46.15M
Weighted Average Shares Outstanding (Diluted)
84.75M 73.81M 65.74M 64.15M 46.15M
Currency in USD

CytomX Therapeutics Earnings and Revenue History